SCOPUS 정보 검색 플랫폼

Cell

Volumn 168, Issue 4, 2017, Pages 579-583

How Much Longer Will We Put Up With 100,000 Cancer Drugs?

(4) Workman, Paul a Draetta, Giulio F b Schellens, Jan H M c,d Bernards, René c

a INSTITUTE OF CANCER RESEARCH (United Kingdom)

b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER (United States)

c NETHERLANDS CANCER INSTITUTE (Netherlands)

d UTRECHT UNIVERSITY (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

COMMERCIAL PHENOMENA; DRUG COST; DRUG DEVELOPMENT; HUMAN; NOTE; PRIORITY JOURNAL; DRUG APPROVAL; ECONOMICS; HEALTH CARE COST; LEGISLATION AND JURISPRUDENCE; NEOPLASMS; UNITED STATES;

ANTINEOPLASTIC AGENTS; DRUG APPROVAL; DRUG COSTS; DRUG DISCOVERY; HEALTH CARE COSTS; HUMANS; NEOPLASMS; UNITED STATES;

EID: 85011955335 PISSN: 00928674 EISSN: 10974172 Source Type: Journal
DOI: 10.1016/j.cell.2017.01.034 Document Type: Note

Times cited : (68)

References (14)

1
- 84929359137
- Avorn, J., N. Engl. J. Med. 372 (2015), 1877–1879.
- (2015) N. Engl. J. Med. , vol.372 , pp. 1877-1879
- Avorn, J.¹

2
- 84979296617
- Banerji, U., Workman, P., Semin. Oncol. 43 (2016), 436–445.
- (2016) Semin. Oncol. , vol.43 , pp. 436-445
- Banerji, U.¹ Workman, P.²

3
- 85029405731
- Brawley, L., Cancer Lett. 42 (2016), 2–18.
- (2016) Cancer Lett. , vol.42 , pp. 2-18
- Brawley, L.¹

4
- 0035338343
- Dimasi, J.A., Clin. Pharmacol. Ther. 69 (2001), 297–307.
- (2001) Clin. Pharmacol. Ther. , vol.69 , pp. 297-307
- Dimasi, J.A.¹

5
- 79957898111
- Frye, S., Crosby, M., Edwards, T., Juliano, R., Nat. Rev. Drug Discov. 10 (2011), 409–410.
- (2011) Nat. Rev. Drug Discov. , vol.10 , pp. 409-410
- Frye, S.¹ Crosby, M.² Edwards, T.³ Juliano, R.⁴

6
- 84860455486
- Hoelder, S., Clarke, P.A., Workman, P., Mol. Oncol. 6 (2012), 155–176.
- (2012) Mol. Oncol. , vol.6 , pp. 155-176
- Hoelder, S.¹ Clarke, P.A.² Workman, P.³

7
- 84922419758
- Howard, D.H., Bach, P.B., Berndt, E.R., Conti, R.M., J. Econ. Perspect. 29 (2015), 139–162.
- (2015) J. Econ. Perspect. , vol.29 , pp. 139-162
- Howard, D.H.¹ Bach, P.B.² Berndt, E.R.³ Conti, R.M.⁴

8
- 84948844971
- Jaffe, S., Lancet 386 (2015), 2127–2128.
- (2015) Lancet , vol.386 , pp. 2127-2128
- Jaffe, S.¹

9
- 84887031063
- Light, D.W., Kantarjian, H., Cancer 119 (2013), 3900–3902.
- (2013) Cancer , vol.119 , pp. 3900-3902
- Light, D.W.¹ Kantarjian, H.²

10
- 84982893727
- Mailankody, S., Prasad, V., JAMA Oncol. 1 (2015), 539–540.
- (2015) JAMA Oncol. , vol.1 , pp. 539-540
- Mailankody, S.¹ Prasad, V.²

11
- 84910630218
- Schultz Kirkegaard, H., Valentin, F., Drug Discov. Today 19 (2014), 1699–1710.
- (2014) Drug Discov. Today , vol.19 , pp. 1699-1710
- Schultz Kirkegaard, H.¹ Valentin, F.²

12
- 84879071011
- Shaw, A.T., Kim, D.-W., Nakagawa, K., Seto, T., Crinó, L., Ahn, M.-J., De Pas, T., Besse, B., Solomon, B.J., Blackhall, F., et al. N. Engl. J. Med. 368 (2013), 2385–2394.
- (2013) N. Engl. J. Med. , vol.368 , pp. 2385-2394
- Shaw, A.T.¹ Kim, D.-W.² Nakagawa, K.³ Seto, T.⁴ Crinó, L.⁵ Ahn, M.-J.⁶ De Pas, T.⁷ Besse, B.⁸ Solomon, B.J.⁹ Blackhall, F.¹⁰

13
- 84911372597
- Shaw, A.T., Ou, S.H., Bang, Y.J., Camidge, D.R., Solomon, B.J., Salgia, R., Riely, G.J., Varella-Garcia, M., Shapiro, G.I., Costa, D.B., et al. N. Engl. J. Med. 371 (2014), 1963–1971.
- (2014) N. Engl. J. Med. , vol.371 , pp. 1963-1971
- Shaw, A.T.¹ Ou, S.H.² Bang, Y.J.³ Camidge, D.R.⁴ Solomon, B.J.⁵ Salgia, R.⁶ Riely, G.J.⁷ Varella-Garcia, M.⁸ Shapiro, G.I.⁹ Costa, D.B.¹⁰

14
- 84955240467
- van Harten, W.H., Wind, A., de Paoli, P., Saghatchian, M., Oberst, S., Lancet Oncol. 17 (2016), 18–20.
- (2016) Lancet Oncol. , vol.17 , pp. 18-20
- van Harten, W.H.¹ Wind, A.² de Paoli, P.³ Saghatchian, M.⁴ Oberst, S.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.